Survodutide Benefits
Clinical TrialsGLP-1 / Weight Loss
FM
Reviewed by Fat Man in the Arena · Updated March 2026
Not medical advice. This content is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer.
How Survodutide works
Activates both GLP-1 and glucagon receptors. The glucagon component increases energy expenditure and hepatic fat oxidation while GLP-1 reduces appetite.
Reported benefits
Based on available research data, Survodutide has been associated with the following benefits:
- Up to 19% weight loss in Phase 2
- Significant liver fat reduction
- Potential MASH treatment
Supporting research
Survodutide for Obesity (Phase 2)
New England Journal of Medicine, 2024 · PMID: 38587239
19.2% body weight loss at highest dose over 46 weeks.
Important context
Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors.
Related peptides
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.